| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 12-12-2025 | ||||||
| NAV | ₹17.29(R) | +0.1% | ₹17.75(D) | +0.1% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 5.22% | -% | -% | -% | -% |
| Direct | 6.46% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.34% | 22.28% | 13.69% | 15.42% | 7.83% | |
| SIP (XIRR) | Regular | 9.51% | -% | -% | -% | -% |
| Direct | 10.81% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/06/2025 | 1682 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | - | ||||
| Sbi Healthcare Opportunities Fund | - | ||||
NAV Date: 12-12-2025
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 17.29 |
0.0200
|
0.1000%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 17.29 |
0.0200
|
0.1000%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 17.75 |
0.0200
|
0.1000%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 17.75 |
0.0200
|
0.1000%
|
Review Date: 12-12-2025
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.60 | 0.95 |
-1.39
|
-2.37 | -0.47 | 2 | 13 | Very Good |
| 3M Return % | -0.88 | 2.12 |
-1.82
|
-3.32 | -0.88 | 1 | 13 | Very Good |
| 6M Return % | 3.81 | 4.02 |
1.17
|
-3.20 | 4.08 | 2 | 13 | Very Good |
| 1Y Return % | 5.22 | 3.34 |
-0.18
|
-4.93 | 5.22 | 1 | 13 | Very Good |
| 1Y SIP Return % | 9.51 |
4.77
|
1.55 | 9.51 | 1 | 13 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.51 | 0.95 | -1.29 | -2.24 | -0.39 | 2 | 13 | Very Good |
| 3M Return % | -0.59 | 2.12 | -1.51 | -2.93 | -0.59 | 1 | 13 | Very Good |
| 6M Return % | 4.42 | 4.02 | 1.83 | -2.41 | 4.97 | 2 | 13 | Very Good |
| 1Y Return % | 6.46 | 3.34 | 1.11 | -3.51 | 6.46 | 1 | 13 | Very Good |
| 1Y SIP Return % | 10.81 | 6.14 | 2.67 | 11.31 | 2 | 13 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 12-12-2025 | 17.289 | 17.753 |
| 11-12-2025 | 17.271 | 17.735 |
| 10-12-2025 | 17.149 | 17.608 |
| 09-12-2025 | 17.19 | 17.65 |
| 08-12-2025 | 17.09 | 17.547 |
| 05-12-2025 | 17.369 | 17.832 |
| 04-12-2025 | 17.423 | 17.887 |
| 03-12-2025 | 17.374 | 17.835 |
| 02-12-2025 | 17.46 | 17.924 |
| 01-12-2025 | 17.488 | 17.951 |
| 28-11-2025 | 17.539 | 18.002 |
| 27-11-2025 | 17.465 | 17.925 |
| 26-11-2025 | 17.489 | 17.95 |
| 25-11-2025 | 17.36 | 17.817 |
| 24-11-2025 | 17.35 | 17.806 |
| 21-11-2025 | 17.348 | 17.802 |
| 20-11-2025 | 17.453 | 17.909 |
| 19-11-2025 | 17.416 | 17.871 |
| 18-11-2025 | 17.426 | 17.88 |
| 17-11-2025 | 17.572 | 18.03 |
| 14-11-2025 | 17.546 | 18.001 |
| 13-11-2025 | 17.401 | 17.852 |
| 12-11-2025 | 17.394 | 17.844 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.